Arvanitis; Argyrios G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arvanitis; Argyrios G..The latest application filed is for "metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentyl- propanenitr".

Company Profile

3.25.32

Arvanitis; Argyrios G. - Kennett Square PA
Arvanitis; Argyrios G - Kennett Square PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITR App 20200038404 - Rodgers; James D. ; et al.	2020-02-06
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentyl- propanenitrile Grant 10,463,667 - Rodgers , et al. No	2019-11-05
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20170326144 - Rodgers; James D. ; et al.	2017-11-16
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylprop- anenitrile Grant 9,512,161 - Rodgers , et al. December 6, 2	2016-12-06
Cyclohexyl azetidine derivatives as JAK inhibitors Grant 9,359,358 - Rodgers , et al. June 7, 2	2016-06-07
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors Grant 9,334,274 - Rodgers , et al. May 10, 2	2016-05-10
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20150164900 - Rodgers; James D. ; et al.	2015-06-18
HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROP- ANENITRILE App 20140378400 - Rodgers; James D. ; et al.	2014-12-25
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentyl- propanenitrile Grant 8,889,697 - Rodgers , et al. November 18, 2	2014-11-18
Substituted heterocycles as janus kinase inhibitors Grant 8,841,318 - Arvanitis , et al. September 23, 2	2014-09-23
Azepine inhibitors of janus kinases Grant 8,835,423 - Arvanitis , et al. September 16, 2	2014-09-16
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20140221379 - Rodgers; James D ; et al.	2014-08-07
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitril- e Grant 8,748,401 - Rodgers , et al. June 10, 2	2014-06-10
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors Grant 8,716,303 - Rodgers , et al. May 6, 2	2014-05-06
Azepine Inhibitors Of Janus Kinases App 20140031344 - Arvanitis; Argyrios G. ; et al.	2014-01-30
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors App 20140005210 - Rodgers; James D. ; et al.	2014-01-02
HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROP- ANENITRILE App 20130345157 - Rodgers; James D. ; et al.	2013-12-26
Azepine inhibitors of Janus kinases Grant 8,563,541 - Arvanitis , et al. October 22, 2	2013-10-22
Substituted Heterocycles As Janus Kinase Inhibitors App 20130274257 - Arvanitis; Argyrios G. ; et al.	2013-10-17
Substituted heterocycles as Janus kinase inhibitors Grant 8,513,270 - Arvanitis , et al. August 20, 2	2013-08-20
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile Grant 8,486,902 - Rodgers , et al. July 16, 2	2013-07-16
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20130137681 - Rodgers; James D. ; et al.	2013-05-30
Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Grant 8,415,362 - Rodgers , et al. April 9, 2	2013-04-09
Cyclohexyl Azetidine Derivatives as JAK Inhibitors App 20130045963 - Rodgers; James D. ; et al.	2013-02-21
Azepine Inhibitors Of Janus Kinases App 20120329782 - Arvanitis; Argyrios G. ; et al.	2012-12-27
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20110224157 - Rodgers; James D. ; et al.	2011-09-15
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20110223210 - Rodgers; James D. ; et al.	2011-09-15
HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE App 20110086810 - RODGERS; James D. ; et al.	2011-04-14
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20110082159 - RODGERS; James D. ; et al.	2011-04-07
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20100298334 - Rodgers; James D. ; et al.	2010-11-25
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20100022522 - Rodgers; James D. ; et al.	2010-01-28
Tetracyclic Inhibitors Of Janus Kinases App 20090215766 - Rodgers; James D. ; et al.	2009-08-27
Azepine Inhibitors Of Janus Kinases App 20090197869 - Arvanitis; Argyrios G. ; et al.	2009-08-06
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20090181959 - Rodgers; James D. ; et al.	2009-07-16
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20080312258 - Rodgers; James D. ; et al.	2008-12-18
Substituted Heterocycles As Janus Kinase Inhibitors App 20080188500 - Arvanitis; Argyrios G. ; et al.	2008-08-07
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands Grant 7,319,100 - Arvanitis , et al. January 15, 2	2008-01-15
Substituted Pyrazinones, Pyridines And Pyrimidines As Corticotropin Releasing Factor Ligands App 20070155740 - Arvanitis; Argyrios G. ; et al.	2007-07-05
Azepine inhibitors of Janus kinases App 20070149506 - Arvanitis; Argyrios G. ; et al.	2007-06-28
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors App 20070135461 - Rodgers; James D. ; et al.	2007-06-14
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands Grant 7,205,306 - Arvanitis , et al. April 17, 2	2007-04-17
Pyrimidine derivatives as corticotropin releasing factor inhibitors Grant 7,112,585 - Hartz , et al. September 26, 2	2006-09-26
Pyridinyl derivatives for the treatment of depression Grant 7,030,145 - Hartz , et al. April 18, 2	2006-04-18
Pyrimidine derivatives as corticotropin releasing factor inhibitors App 20040229891 - Hartz, Richard A. ; et al.	2004-11-18
Pyridinyl derivatives for the treatment of depression App 20040209917 - Hartz, Richard A. ; et al.	2004-10-21
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands App 20030171380 - Arvanitis, Argyrios G. ; et al.	2003-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.